{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T16:37:14Z","timestamp":1773765434090,"version":"3.50.1"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T00:00:00Z","timestamp":1414368000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0109702","type":"journal-article","created":{"date-parts":[[2014,10,27]],"date-time":"2014-10-27T17:47:38Z","timestamp":1414432058000},"page":"e109702","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Factors Associated with Beta-Cell Dysfunction in Type 2 Diabetes: The BETADECLINE Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Giuseppina T.","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Bruno","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Cercone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Nicolucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"Cucinotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of BetaDecline Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,10,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors","volume":"289","author":"AH Mokdad","year":"2001","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes","volume":"46","author":"SE Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diacare.25.2.330","article-title":"U.K. Prospective Diabetes Study Group. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57)","volume":"25","author":"A Wright","year":"2002","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ijo.2012.205","article-title":"Impact of obesity severity and duration on pancreatic \u03b2- and \u03b1-cell dynamics in normoglycemic non-human primates","volume":"37","author":"R Guardado-Mendoza","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.1104345","article-title":"Type 2 diabetes-a matter of beta-cell life and death?","volume":"307","author":"CJ Rhodes","year":"2005","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.biocel.2006.09.007","article-title":"Apoptosis in the pathophysiology of diabetes mellitus","volume":"39","author":"SC Lee","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"e28050","DOI":"10.1371\/journal.pone.0028050","article-title":"Altered insulin receptor signalling and \u03b2-cell cycle dynamics in type 2 diabetes mellitus","volume":"6","author":"F Folli","year":"2011","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2337\/diabetes.50.6.1290","article-title":"High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program","volume":"50","author":"M Federici","year":"2001","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1073\/pnas.93.8.3492","article-title":"Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide","volume":"93","author":"CB Verchere","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"13992","DOI":"10.1073\/pnas.0906471106","article-title":"Pancreatic islet amyloidosis, beta-cell apoptosis, and alpha-cell proliferationare determinants of islet remodeling in type-2 diabetic baboons","volume":"106","author":"R Guardado-Mendoza","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ajpath.2011.02.036","article-title":"\u03b2-cell loss and \u03b2-cell apoptosis in human type 2 diabetes are related to islet amyloid deposition","volume":"178","author":"CA Jurgens","year":"2011","journal-title":"Am J Pathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"P Westermark","year":"2011","journal-title":"Physiol Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1172\/JCI26052","article-title":"Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha","volume":"115","author":"M Federici","year":"2005","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00125-009-1451-3","article-title":"Impaired regulation of the TNF-alpha converting enzyme\/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans","volume":"52","author":"A Monroy","year":"2009","journal-title":"Diabetologia"},{"key":"ref15","first-page":"2153","article-title":"Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study Diabetologia","volume":"56","author":"D Tripathy","year":"2013"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"WT Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"TM Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1463-1326.2008.00945.x","article-title":"An examination of beta-cell function measures and their potential use for estimating beta-cell mass","volume":"10 Suppl 4","author":"SE Kahn","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.2337\/diabetes.54.8.2404","article-title":"Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin","volume":"54","author":"AE Kitabchi","year":"2005","journal-title":"Diabetes"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"C Weyer","year":"1999","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00125-009-1614-2","article-title":"ACT NOW Study Group. Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study","volume":"53","author":"RA DeFronzo","year":"2010","journal-title":"Diabetologia"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"SE Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.numecd.2007.05.004","article-title":"Protection of pancreatic beta-cells: is it feasible?","volume":"18","author":"E Bonora","year":"2008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/ijcp.12154","article-title":"Choice of early treatment regimen and impact on \u03b2-cell preservation in type 2 diabetes","volume":"67","author":"S Mudaliar","year":"2013","journal-title":"Int J Clin Pract"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/jcem-42-2-222","article-title":"Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests","volume":"42","author":"JD Brunzell","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1464-5491.1994.tb00273.x","article-title":"Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion","volume":"11","author":"DI Phillips","year":"1994","journal-title":"Diabet Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1753-0407.2009.00016.x","article-title":"Insulin secretory function in type 2 diabetes: Does it matter how you measure it?","volume":"1","author":"GM Reaven","year":"2009","journal-title":"J Diabetes"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/db07-0954","article-title":"Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test","volume":"57","author":"A Festa","year":"2008","journal-title":"Diabetes"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6823-10-21","article-title":"Associations of age with serum insulin, proinsulin and the proinsulin-to-insulin ratio: a cross-sectional study","volume":"10","author":"B Bryhni","year":"2010","journal-title":"BMC Endocr Disord"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diacare.22.4.609","article-title":"Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes","volume":"22","author":"ME R\u00f8der","year":"1999","journal-title":"Diabetes Care"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.2337\/diacare.28.11.2745","article-title":"Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S","volume":"28","author":"ES Ford","year":"2005","journal-title":"Diabetes Care"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.yfrne.2009.03.004","article-title":"Sexual differences in the control of energy homeostasis","volume":"30","author":"H Shi","year":"2009","journal-title":"Front Neuroendocrinol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Women's Health Initiative Investigators. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial","volume":"47","author":"KL Margolis","year":"2004","journal-title":"Diabetologia"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Heart and Estrogen\/progestin Replacement Study. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen\/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"AM Kanaya","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s00125-005-1930-0","article-title":"Oestrogens and insulin secretion","volume":"48","author":"IF Godsland","year":"2005","journal-title":"Diabetologia"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrendo.2011.242","article-title":"Importance of oestrogen receptors to preserve functional \u03b2-cell mass in diabetes","volume":"8","author":"JP Tiano","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.0602956103","article-title":"Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice","volume":"103","author":"C Le May","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1038\/oby.2010.44","article-title":"Adiposity and \u03b2-cell function: relationships differ with ethnicity and age","volume":"18","author":"PC Chandler-Laney","year":"2010","journal-title":"Obesity"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5414\/CPP44014","article-title":"Disproportionately elevated proinsulin levels in type 2 diabetic patients treated with sulfonylurea","volume":"44","author":"M Dworacka","year":"2006","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/dia.2006.8.375","article-title":"The switch from sulfonylurea to preprandial short-acting insulin analog substitution has an immediate and comprehensive beta-cell protective effect in patients with type 2 diabetes mellitus","volume":"8","author":"A Pf\u00fctzner","year":"2006","journal-title":"Diabetes Technol Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2337\/db10-1392","article-title":"ADOPT Study. Effects of rosiglitazone, glyburide, and metformin on \u03b2-cell function and insulin sensitivity in ADOPT","volume":"60","author":"SE Kahn","year":"2011","journal-title":"Diabetes"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1177\/193229681100500333","article-title":"Elevated intact proinsulin levels are indicative of Beta-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent pioglitazone","volume":"5","author":"A Pf\u00fctzner","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.2337\/dc13-0184","article-title":"Sex Disparities in the Quality of Diabetes Care: Biological and Cultural Factors May Play a Different Role for Different Outcomes: A cross-sectional observational study from the AMD Annals initiative","volume":"36","author":"MC Rossi","year":"2013","journal-title":"Diabetes Care"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.numecd.2010.01.008","article-title":"Cardiovascular risk in women with diabetes","volume":"20","author":"AA Rivellese","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2337\/diabetes.52.7.1738","article-title":"Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance","volume":"52","author":"R Basu","year":"2003","journal-title":"Diabetes"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2337\/dc11-1272","article-title":"Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study","volume":"35","author":"VD De Mello","year":"2012","journal-title":"Diabetes Care"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.2337\/db11-0415","article-title":"Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes","volume":"60","author":"RJ Strawbridge","year":"2011","journal-title":"Diabetes"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0109702","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T05:08:30Z","timestamp":1598418510000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0109702"}},"subtitle":[],"editor":[{"given":"Franco","family":"Folli","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,27]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0109702","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,27]]}}}